
Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today that Antitrust Partner David Reichenberg has joined the Firm in its New York office. Reichenberg’s extensive antitrust experience across litigation, transactional, regulatory and strategic counseling matters further strengthens Manatt’s national capabilities for clients across key industries, including health care, financial services, entertainment and technology, among others.
“The Firm’s integration of legal and consulting offerings promotes the level of collaboration needed to provide innovative strategies and effective results for my clients, and I’m excited to start this next chapter in my career.”
“We are thrilled to add David to our talented antitrust and trial-ready litigation teams that continue to provide favorable results for clients across our core practices and throughout the nation,” said Donna L. Wilson, Manatt’s CEO and Managing Partner.
“Also a distinguished business adviser and respected thought leader, David brings impressive industry knowledge of complex antitrust disputes and implications that will deepen our abilities to help clients structure and meet their business objectives while minimizing issues with regulators, competitors and other third parties,” Wilson continues.
Following closely on the heels of notable Antitrust Partner Stephen D. Libowsky—who guides clients through issues in litigation, regulatory and transactional matters out of Manatt’s Chicago office—Reichenberg is the latest addition to the Firm’s growing antitrust capabilities. Representing clients ranging from emerging companies to Fortune 500 corporations on various antitrust claims, Reichenberg has deep litigation experience on both the plaintiff and defense sides and regularly advises companies of all sizes on the antitrust implications of potential business initiatives.
Reichenberg also advises on and litigates unfair competition issues, including intellectual property and trade secrets-related matters. Additionally, he has guided clients before the U.S. Department of Justice and the Federal Trade Commission, coordinating responses to government investigations from both offensive and defensive perspectives. Reichenberg has been previously named to Global Competition Review’s “40 Under 40” quadrennial list, which recognizes the top antitrust lawyers in the world under the age of 40.
“David’s impressive and deep experience across sectors handling complex matters makes him a terrific addition in New York and will add depth to some of our core industry offerings in the office, which span from health care to digital and technology,” said Prana A. Topper, Manatt’s New York Office Managing Partner. “Our diverse New York-based legal and consulting colleagues are constantly collaborating and working with professionals across all our offices, so it is also the ideal place for David to continue growing his national practice and help clients navigate today’s regulatory landscape.”
A dedicated member of his community, Reichenberg also regularly engages in pro bono efforts. He has represented individual civil rights plaintiffs in federal court and most recently served as first chair on a trial team that secured a favorable jury verdict against a 1983 claim under the Fourth Amendment in the Eastern District of New York.
“I was immediately drawn to Manatt’s entrepreneurial approach to client services and its excellent reputation as a strategic adviser across the board,” said Reichenberg. “The Firm’s integration of legal and consulting offerings promotes the level of collaboration needed to provide innovative strategies and effective results for my clients, and I’m excited to start this next chapter in my career.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas